15.98
price up icon1.20%   0.19
 
loading
전일 마감가:
$15.79
열려 있는:
$15.88
하루 거래량:
1.81M
Relative Volume:
0.79
시가총액:
$4.15B
수익:
$6.41B
순이익/손실:
$1.30B
주가수익비율:
6.9782
EPS:
2.29
순현금흐름:
$646.00M
1주 성능:
+8.49%
1개월 성능:
-6.88%
6개월 성능:
-23.87%
1년 성능:
+39.81%
1일 변동 폭
Value
$15.88
$16.15
1주일 범위
Value
$14.75
$16.29
52주 변동 폭
Value
$10.84
$23.10

오가논 & Co Stock (OGN) Company Profile

Name
명칭
Organon Co
Name
전화
551-430-6000
Name
주소
30 HUDSON STREET, JERSEY CITY
Name
직원
10,000
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
OGN's Discussions on Twitter

OGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
OGN
Organon Co
15.98 4.15B 6.41B 1.30B 646.00M 2.29
Drug Manufacturers - General icon
LLY
Lilly Eli Co
788.19 752.65B 40.86B 8.37B -2.28B 5.4193
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
106.13 471.56B 39.36B 13.79B 9.83B 2.4077
Drug Manufacturers - General icon
JNJ
Johnson Johnson
155.40 353.35B 87.70B 14.68B 19.03B 13.47
Drug Manufacturers - General icon
ABBV
Abbvie Inc
183.08 323.72B 55.53B 5.12B 15.62B 3.65
Drug Manufacturers - General icon
MRK
Merck Co Inc
103.12 260.72B 63.17B 12.15B 14.84B 1.80

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-09-06 다운그레이드 JP Morgan Neutral → Underweight
2023-11-03 다운그레이드 Goldman Buy → Neutral
2023-09-21 개시 Barclays Overweight
2023-03-16 개시 Raymond James Outperform
2022-10-14 다운그레이드 BofA Securities Neutral → Underperform
2022-09-06 업그레이드 Piper Sandler Neutral → Overweight
2022-08-05 다운그레이드 BofA Securities Buy → Neutral
2022-04-27 개시 Goldman Buy
2022-04-06 재개 Morgan Stanley Equal-Weight
2021-10-07 개시 Piper Sandler Neutral
2021-09-01 개시 BofA Securities Buy
2021-07-22 개시 Citigroup Buy
2021-06-15 개시 JP Morgan Neutral
2021-06-11 개시 Morgan Stanley Equal-Weight
2021-06-10 개시 Evercore ISI Outperform
모두보기

오가논 & Co 주식(OGN)의 최신 뉴스

pulisher
Nov 27, 2024

Algert Global LLC Has $2.20 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Nov 26, 2024
pulisher
Nov 26, 2024

Organon & Co. (OGN): An Oversold Healthcare Stock to Invest In Now - Insider Monkey

Nov 26, 2024
pulisher
Nov 26, 2024

Cerity Partners LLC Has $12.77 Million Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 26, 2024
pulisher
Nov 24, 2024

(OGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 24, 2024
pulisher
Nov 24, 2024

Organon & Co. (NYSE:OGN) Stock Position Lifted by Victory Capital Management Inc. - MarketBeat

Nov 24, 2024
pulisher
Nov 23, 2024

Massachusetts Financial Services Co. MA Sells 332,614 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune

Nov 22, 2024
pulisher
Nov 21, 2024

Thompson Siegel & Walmsley LLC Raises Stake in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 21, 2024
pulisher
Nov 21, 2024

Foundry Partners LLC Takes $7.64 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 21, 2024
pulisher
Nov 21, 2024

Reach For A Dream and Organon Collaborate to Launch Dream Room at Rahima Moosa Mother and Child Hospital - Media Update

Nov 21, 2024
pulisher
Nov 20, 2024

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Organon partners with Egyptian Drug Authority to advance women’s health and family planning in Egypt - ZAWYA

Nov 19, 2024
pulisher
Nov 19, 2024

Beddow Capital Management Inc. Raises Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 19, 2024
pulisher
Nov 14, 2024

Organon: 7% Yield, 4x P/E, Big Upside Potential (NYSE:OGN) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 14, 2024

(OGN) Proactive Strategies - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Organon & Co. (NYSE:OGN) Shares Sold by Principal Financial Group Inc. - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Organon & Co. (NYSE:OGN) Stock Holdings Decreased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) - Seeking Alpha

Nov 13, 2024
pulisher
Nov 13, 2024

Organon & Co (OGN) Stock Price Down 3.48% on Nov 12 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Amalgamated Bank Sells 34,385 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Los Angeles Capital Management LLC Boosts Stake in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 12, 2024
pulisher
Nov 09, 2024

Acorn Financial Advisory Services Inc. ADV Takes $743,000 Position in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Van ECK Associates Corp Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Philip James Wealth Mangement LLC Invests $15.39 Million in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Ex-Dividend Reminder: American Water Works, Essential Utilities Inc and Organon - Nasdaq

Nov 08, 2024
pulisher
Nov 08, 2024

Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Simply Wall St

Nov 08, 2024
pulisher
Nov 07, 2024

Organon & Co (OGN) Stock Price Up 2.82% on Nov 7 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

FDA extends Organon's VTAMA cream review to March 2025 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 05, 2024

Organon & Co. (NYSE:OGN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Relative Strength Alert For Organon - Nasdaq

Nov 05, 2024
pulisher
Nov 05, 2024

Organon updates outlook as FDA delays VTAMA label expansion - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Organon reports FDA extension of target action date of review of Vtama sNDA - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Organon’s VTAMA Cream FDA Review Extended to 2025 - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Organon stock on watch as FDA delays VTAMA label (OGN:NYSE) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

FDA extends Organon's VTAMA cream review to March 2025 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

(tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older - Business Wire

Nov 05, 2024
pulisher
Nov 05, 2024

Organon's SWOT analysis: stock outlook amid VTAMA potential and biosimilar growth - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Organon & Co (OGN) Stock Price Down 6.38% on Nov 4 - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Organon & Co. (NYSE:OGN) Trading Down 4.4%Should You Sell? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Simply Wall St

Nov 04, 2024
pulisher
Nov 03, 2024

Organon China’s License and Supply Agreement with Shanghai Bao Pharmaceuticals - Global Legal Chronicle

Nov 03, 2024
pulisher
Nov 03, 2024

(OGN) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 03, 2024

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28 - Yahoo Finance

Nov 03, 2024
pulisher
Nov 02, 2024

Organon (OGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Private Management Group Inc. Has $36.23 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023) - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Organon & Co. (NYSE:OGN) to Issue $0.28 Quarterly Dividend - MarketBeat

Nov 01, 2024

오가논 & Co (OGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general BMY
$59.27
price up icon 0.90%
drug_manufacturers_general SNY
$48.72
price up icon 0.91%
drug_manufacturers_general PFE
$25.83
price up icon 0.23%
$280.07
price up icon 0.02%
drug_manufacturers_general NVS
$104.87
price up icon 1.02%
drug_manufacturers_general MRK
$103.12
price up icon 1.48%
자본화:     |  볼륨(24시간):